# åƒè€ƒæ–‡ç» PDF æ¸…å–®

## å°ç£ä¸‰é«˜é æ¸¬ç›¸é—œè«–æ–‡

### é«˜å„ªå…ˆç´šè«–æ–‡

#### 1. Liu et al. (2024) - å°ç£ç¬¬äºŒå‹ç³–å°¿ç—… 10 å¹´é æ¸¬
- **æª”å**: `diagnostics-15-00072.pdf`
- **æ¨™é¡Œ**: Use of Machine Learning to Predict the Incidence of Type 2 Diabetes Among Relatively Healthy Adults: A 10-Year Longitudinal Study in Taiwan
- **æœŸåˆŠ**: Diagnostics, 15(1), 72
- **é€£çµ**: https://www.mdpi.com/2075-4418/15/1/72
- **DOI**: 10.3390/diagnostics15010072
- **ç™¼è¡¨æ—¥æœŸ**: 2024å¹´12æœˆ
- **é—œéµå­—**: Type 2 Diabetes, Machine Learning, Random Forest, Taiwan, Longitudinal Study
- **é‡è¦æ€§**: â­â­â­â­â­ æœ€æ–°å°ç£ç³–å°¿ç—…é æ¸¬ç ”ç©¶ï¼Œ10å¹´è¿½è¹¤ï¼Œæº–ç¢ºç‡99%

---

#### 2. Hung et al. (2021) - å°ç£éš±åŒ¿æ€§é«˜è¡€å£“æ©Ÿå™¨å­¸ç¿’é æ¸¬
- **æª”å**: `fcvm-08-778306.pdf`
- **æ¨™é¡Œ**: Prediction of Masked Hypertension and Masked Uncontrolled Hypertension Using Machine Learning
- **æœŸåˆŠ**: Frontiers in Cardiovascular Medicine, 8:778306
- **é€£çµ**: https://www.frontiersin.org/journals/cardiovascular-medicine/articles/10.3389/fcvm.2021.778306/full
- **DOI**: 10.3389/fcvm.2021.778306
- **ç™¼è¡¨æ—¥æœŸ**: 2021å¹´11æœˆ
- **é—œéµå­—**: Masked Hypertension, Machine Learning, Random Forest, SMOTE, External Validation
- **é‡è¦æ€§**: â­â­â­â­â­ å°ç£å¤šä¸­å¿ƒç ”ç©¶ï¼Œå®Œæ•´çš„ ML pipeline èˆ‡å¤–éƒ¨é©—è­‰

---

### ğŸ¯ å¤šç–¾ç—…åŒæ™‚é æ¸¬è«–æ–‡ï¼ˆMulti-Disease / Multi-Task Learningï¼‰

#### 3. Taiwan MTL (2025) - å°ç£å¤šä»»å‹™å­¸ç¿’é æ¸¬æ…¢æ€§ç—… â­ æ¥µåº¦ç›¸é—œ
- **æª”å**: ï¼ˆå¾…ä¸‹è¼‰ï¼‰
- **æ¨™é¡Œ**: Multitask learning multimodal network for chronic disease prediction
- **æœŸåˆŠ**: Scientific Reports (2025å¹´5æœˆ)
- **é€£çµ**: https://www.nature.com/articles/s41598-025-99554-z
- **DOI**: 10.1038/s41598-025-99554-z
- **ç™¼è¡¨æ—¥æœŸ**: 2025å¹´5æœˆ
- **é—œéµå­—**: Multi-Task Learning, Multimodal, Diabetes, Hypertension, Heart Disease, Stroke, Taiwan
- **é æ¸¬ç›®æ¨™**: åŒæ™‚é æ¸¬ 4 ç¨®ç–¾ç—…ï¼ˆç³–å°¿ç—…ã€å¿ƒè‡Ÿç—…ã€ä¸­é¢¨ã€é«˜è¡€å£“ï¼‰
- **é‡è¦æ€§**: â­â­â­â­â­ **èˆ‡æœ¬ç ”ç©¶é«˜åº¦ç›¸é—œ**ï¼å°ç£è³‡æ–™ã€å¤šä»»å‹™å­¸ç¿’æ¡†æ¶ã€å¤šç–¾ç—…åŒæ™‚é æ¸¬
- **é—œéµç™¼ç¾**:
  - ä½¿ç”¨ Multi-Task Learning æ•æ‰ç–¾ç—…é–“çš„ç›¸é—œæ€§
  - ä½¿ç”¨è¼ƒå°‘ç‰¹å¾µä»ä¿æŒå¼·é æ¸¬èƒ½åŠ›
  - å¼·èª¿ç–¾ç—…é–“çš„å…±åŒé¢¨éšªå› å­

---

#### 4. DHDIP (2022) - é«˜è¡€å£“èˆ‡é«˜è¡€è„‚è¯åˆé æ¸¬
- **æª”å**: ï¼ˆå¾…ä¸‹è¼‰ï¼‰
- **æ¨™é¡Œ**: DHDIP: An interpretable model for hypertension and hyperlipidemia prediction based on EMR data
- **æœŸåˆŠ**: Computer Methods and Programs in Biomedicine
- **é€£çµ**: https://www.sciencedirect.com/science/article/abs/pii/S0169260722004692
- **ç™¼è¡¨æ—¥æœŸ**: 2022å¹´
- **é—œéµå­—**: Multi-Objective Learning, Hypertension, Hyperlipidemia, Interpretability, EMR
- **é æ¸¬ç›®æ¨™**: åŒæ™‚é æ¸¬é«˜è¡€å£“å’Œé«˜è¡€è„‚çš„ç”ŸåŒ–æŒ‡æ¨™
- **é‡è¦æ€§**: â­â­â­â­ é«˜æ€§èƒ½ + é«˜å¯è§£é‡‹æ€§ï¼Œæ–¹æ³•è«–å¯åƒè€ƒ
- **é—œéµç™¼ç¾**:
  - Multi-objective learning æ–¹æ³•
  - å¯è§£é‡‹æ€§æ¨¡å‹è¨­è¨ˆ
  - é‡å°ç”ŸåŒ–æŒ‡æ¨™çš„é æ¸¬

---

#### 5. Multi-Disease Prediction (2010) - é«˜è¡€å£“èˆ‡é«˜è¡€è„‚å…±åŒé¢¨éšªå› å­
- **æª”å**: ï¼ˆå¾…ä¸‹è¼‰ï¼‰
- **æ¨™é¡Œ**: Using data mining techniques for multi-diseases prediction modeling of hypertension and hyperlipidemia by common risk factors
- **æœŸåˆŠ**: Expert Systems with Applications
- **é€£çµ**: https://www.sciencedirect.com/science/article/abs/pii/S0957417410012303
- **ç™¼è¡¨æ—¥æœŸ**: 2010å¹´
- **é—œéµå­—**: Data Mining, Common Risk Factors, Hypertension, Hyperlipidemia, Two-Phase Approach
- **é æ¸¬ç›®æ¨™**: åŒæ™‚é æ¸¬é«˜è¡€å£“å’Œé«˜è¡€è„‚
- **é‡è¦æ€§**: â­â­â­ ç¶“å…¸çš„å…©éšæ®µå¤šç–¾ç—…é æ¸¬æ–¹æ³•
- **æ–¹æ³•**:
  - Phase 1: é¸æ“‡å€‹åˆ¥é¢¨éšªå› å­
  - Phase 2: ä½¿ç”¨æŠ•ç¥¨åŸå‰‡æ‰¾å‡ºå…±åŒé¢¨éšªå› å­

---

### ä¸­å„ªå…ˆç´šè«–æ–‡

#### 6. Dual Machine Learning Framework (2025) - å°ç£å‰é©…ç³–å°¿ç—…é æ¸¬
- **æª”å**: `Dual_Framework_2025_Taiwan_Prediabetes.pdf`ï¼ˆå¾…ä¸‹è¼‰ï¼‰
- **æ¨™é¡Œ**: Dual Machine Learning Framework for Predicting Long-Term Glycemic Change and Prediabetes Risk in Young Taiwanese Men
- **æœŸåˆŠ**: Diagnostics, 15(19), 2507
- **é€£çµ**: ï¼ˆå¾…è£œå……ï¼‰
- **ç™¼è¡¨æ—¥æœŸ**: 2025å¹´
- **é—œéµå­—**: Prediabetes, Dual Framework, SHAP, Taiwan Biobank, Î´-FPG
- **é‡è¦æ€§**: â­â­â­â­ ç¸±å‘è¡€ç³–è®ŠåŒ–é æ¸¬ï¼Œé›™æ¡†æ¶è¨­è¨ˆå€¼å¾—åƒè€ƒ

---

#### 7. Chen & Huang (2023) - å°ç£ç³–å°¿ç—…ç¥ç¶“ç¶²è·¯é æ¸¬
- **æª”å**: `Chen_2023_Taiwan_Diabetes_ANN.pdf`ï¼ˆå¾…ä¸‹è¼‰ï¼‰
- **æ¨™é¡Œ**: Predicting the Onset of Diabetes with Machine Learning Methods
- **æœŸåˆŠ**: Journal of Personalized Medicine, 13(3), 406
- **é€£çµ**: ï¼ˆå¾…è£œå……ï¼‰
- **ç™¼è¡¨æ—¥æœŸ**: 2023å¹´
- **é—œéµå­—**: Diabetes, Neural Network, Boosted Decision Tree
- **é‡è¦æ€§**: â­â­â­ AUC 0.991ï¼Œè­‰æ˜æ·±åº¦å­¸ç¿’å¯è¡Œæ€§

---

## ä¸‹è¼‰ç‹€æ…‹

### é«˜å„ªå…ˆç´š
- [x] Liu et al. (2024) - å·²ä¸‹è¼‰ âœ…
- [x] Hung et al. (2021) - å·²ä¸‹è¼‰ âœ…

### å¤šç–¾ç—…åŒæ™‚é æ¸¬ï¼ˆæ¥µåº¦ç›¸é—œï¼‰
- [ ] Taiwan MTL (2025) - å¾…ä¸‹è¼‰ ğŸ¯ **å¼·çƒˆå»ºè­°å„ªå…ˆä¸‹è¼‰**
- [ ] DHDIP (2022) - å¾…ä¸‹è¼‰
- [ ] Multi-Disease Prediction (2010) - å¾…ä¸‹è¼‰

### ä¸­å„ªå…ˆç´š
- [ ] Dual Framework (2025) - å¾…ä¸‹è¼‰
- [ ] Chen & Huang (2023) - å¾…ä¸‹è¼‰


---

## ğŸ”¬ ä¸­åœ‹æ±å—éƒ¨ç¤¾å€èª¿æŸ¥æ•¸æ“šé›†ï¼ˆ2010-2018ï¼‰

### 8. Lin et al. (2024) - å°¿é…¸æ§åˆ¶èˆ‡é«˜è¡€å£“é¢¨éšª ğŸ¯ **ç›¸åŒ Dataset**
- **æª”å**: `fendo-15-1343998.pdf`
- **æ¨™é¡Œ**: Poor serum uric acid control increases risk for developing hypertension: a retrospective cohort study in China
- **ä½œè€…**: Lin Z, Wu S, Chen Z, Luo W, Lin Z, Su H, Guo D
- **æœŸåˆŠ**: Frontiers in Endocrinology
- **DOI**: 10.3389/fendo.2024.1343998
- **ç™¼è¡¨æ—¥æœŸ**: 2024å¹´1æœˆ31æ—¥
- **ç¶²é é€£çµ**: https://www.frontiersin.org/articles/10.3389/fendo.2024.1343998/full
- **è³‡æ–™ä¾†æº**: ä¸­åœ‹æ±å—éƒ¨ç¤¾å€èª¿æŸ¥ï¼ˆ2010-2018ï¼‰
- **ç ”ç©¶é¡å‹**: å›é¡§æ€§ä¸–ä»£ç ”ç©¶
- **ç ”ç©¶é‡é»**:
  - è¡€æ¸…å°¿é…¸æ§åˆ¶ä¸è‰¯èˆ‡é«˜è¡€å£“ç™¼ç—…é¢¨éšª
  - ä¸­åœ‹ç¤¾å€äººç¾¤çš„é•·æœŸè¿½è¹¤æ•¸æ“š

---

### 9. Guo et al. (2025) - å°¿é…¸èˆ‡ç¸½è†½å›ºé†‡çš„åŠ‘é‡åæ‡‰é—œä¿‚ ğŸ¯ **ç›¸åŒ Dataset**
- **æª”å**: `guo-et-al-2025-the-dose-response-relationship-and-gender-differences-of-serum-uric-acid-with-total-cholesterol-a-cross.pdf`
- **æ¨™é¡Œ**: The dose-response relationship and gender differences of serum uric acid with total cholesterol: a cross-sectional study
- **ä½œè€…**: Leilei Guo, Lina Cai, Li Hu, Yueshan Zhou
- **æœŸåˆŠ**: Journal of International Medical Research, 2025, Vol. 53(2) 1â€“15
- **DOI**: 10.1177/03000605251318203
- **ç™¼è¡¨æ—¥æœŸ**: 2025å¹´1æœˆ17æ—¥ï¼ˆæ¥å—ï¼‰
- **è³‡æ–™ä¾†æº**: ä¸­åœ‹æ±å—éƒ¨ç¤¾å€èª¿æŸ¥ï¼ˆ2010-2018ï¼‰- **èˆ‡ Lin et al. (2024) ç›¸åŒæ•¸æ“šé›†**
- **ç ”ç©¶é¡å‹**: æ©«æ–·é¢ç ”ç©¶
- **æ¨£æœ¬æ•¸**: 6,119 ä½æˆäººï¼ˆå¥³æ€§ 4,078 äººï¼Œ66.6%ï¼›å¹³å‡å¹´é½¡ 63.7 æ­²ï¼‰
- **ç ”ç©¶é‡é»**:
  - è¡€æ¸…å°¿é…¸ï¼ˆSUAï¼‰èˆ‡ç¸½è†½å›ºé†‡ï¼ˆTCï¼‰çš„åŠ‘é‡åæ‡‰é—œä¿‚
  - æ€§åˆ¥å·®ç•°åˆ†æ
  - å¥³æ€§ï¼šå€’ L å‹é—œä¿‚ï¼ˆæ‹é» 359.962 Î¼mol/Lï¼‰
  - ç”·æ€§ï¼šç·šæ€§é—œä¿‚
  - SUA æ¯å¢åŠ  100 å–®ä½ï¼Œç”·æ€§ TC Î²=0.09ï¼Œå¥³æ€§ TC Î²=0.13
- **é—œéµç™¼ç¾**:
  - å¥³æ€§åœ¨ SUA < 359.962 Î¼mol/L æ™‚ï¼ŒTC éš¨ SUA å‡é«˜è€Œå¢åŠ 
  - ç”·æ€§å‘ˆç¾ç·šæ€§æ­£ç›¸é—œ
  - å¥³æ€§çš„é—œè¯å¼·åº¦é¡¯è‘—é«˜æ–¼ç”·æ€§
  - å¹´é½¡åˆ†å±¤é¡¯ç¤ºå¥³æ€§ <60 æ­²å­˜åœ¨äº¤äº’ä½œç”¨ï¼ˆP=0.034ï¼‰

---

## ç­†è¨˜

- è©³ç´°æ–‡ç»å›é¡§è«‹è¦‹ï¼š[Q2_Taiwan_Literature_Review.md](../Q2_Taiwan_Literature_Review.md)
- è«–æ–‡é–±è®€ç­†è¨˜æ”¾åœ¨ï¼š[literature_notes/](../literature_notes/)